跨越癌症和COVID-19:ACE2和TMPRSS2的复杂相互作用
Xuerui Tang1, Liuzhi Lu1, Xiaoping Li2
1School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.
Cancer medicine
|March 27, 2025
概括
癌症患者面临更高的COVID-19风险. 本综述探讨了ACE2和TMPRSS2如何影响SARS-CoV-2感染的癌症,突出了复杂的角色和个性化治疗需求.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 由于癌症和治疗的免疫抑制,癌症患者面临严重COVID-19结局的风险增加.
- SARS-CoV-2 病毒利用 ACE2 作为其主要进入受体,并利用 TMPRSS2 促进病毒进入.
研究的目的:
- 在癌症背景下调查ACE2和TMPRSS2在SARS-CoV-2感染中的双重作用.
- 分析ACE2和TMPRSS2表达对癌症进展,病毒易感性和患者预后的影响.
- 为患有COVID-19的癌症患者提出个性化的治疗策略.
主要方法:
- 对各种癌症类型中ACE2和TMPRSS2表达的现有文献的综述.
- 分析ACE2/TMPRSS2水平,免疫细胞透和患者结果之间的相关性.
- 在SARS-CoV-2感染的癌症患者中探索ACE2和TMPRSS2的治疗向策略.
主要成果:
- 在某些癌症 (如肺癌,结肠癌) 中,ACE2 过度表达,可能会增加病毒易感性,但也具有瘤抑制作用.
- 在不同瘤中,TMPRSS2的表达不同,在前列腺癌和肺癌中具有预后意义.
- 由于ACE2和TMPRSS2的复杂且往往相互矛盾的作用,对治疗向提出了挑战.
结论:
- 针对ACE2和TMPRSS2需要仔细考虑它们在病毒进入和癌症生物学中的多方面的作用.
- 基于分子形状的个人化医疗方法,整合抗病毒和癌症疗法,对于管理COVID-19的癌症患者至关重要.
- 多学科策略对于优化这种脆弱患者群体的治疗结果至关重要.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.6K
03:42High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
Published on: May 18, 2022
2.2K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
